These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27042856)

  • 1. Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis.
    Kikutake C; Yahara K
    PLoS One; 2016; 11(4):e0152918. PubMed ID: 27042856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines.
    Suzuki A; Makinoshima H; Wakaguri H; Esumi H; Sugano S; Kohno T; Tsuchihara K; Suzuki Y
    Nucleic Acids Res; 2014 Dec; 42(22):13557-72. PubMed ID: 25378332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells.
    Lu Y; Liu Y; Liao S; Tu W; Shen Y; Yan Y; Tao D; Lu Y; Ma Y; Yang Y; Zhang S
    Oncotarget; 2016 Jul; 7(28):43162-43176. PubMed ID: 27281610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma.
    Lenka G; Tsai MH; Lin HC; Hsiao JH; Lee YC; Lu TP; Lee JM; Hsu CP; Lai LC; Chuang EY
    Sci Rep; 2017 Feb; 7():42573. PubMed ID: 28198450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
    Zhang QH; Dai XH; Dai ZM; Cai YN
    Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
    Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
    Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
    [No Abstract]   [Full Text] [Related]  

  • 7. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
    Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
    Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone ChIP-Seq identifies differential enhancer usage during chondrogenesis as critical for defining cell-type specificity.
    Cheung K; Barter MJ; Falk J; Proctor CJ; Reynard LN; Young DA
    FASEB J; 2020 Apr; 34(4):5317-5331. PubMed ID: 32058623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.
    Zhu Y; Lu H; Zhang D; Li M; Sun X; Wan L; Yu D; Tian Y; Jin H; Lin A; Gao F; Lai M
    Clin Epigenetics; 2018; 10():30. PubMed ID: 29507648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma.
    Li Q; Chen C; Ren X; Sun W
    Oncotarget; 2017 May; 8(20):33100-33109. PubMed ID: 28380439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation biomarkers for the occurrence of lung adenocarcinoma from TCGA data mining.
    Zhu XF; Zhu BS; Wu FM; Hu HB
    J Cell Physiol; 2018 Oct; 233(10):6777-6784. PubMed ID: 29667778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters.
    Yoo S; Bieda MC
    BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the human thyroid epigenome.
    Siu C; Wiseman S; Gakkhar S; Heravi-Moussavi A; Bilenky M; Carles A; Sierocinski T; Tam A; Zhao E; Kasaian K; Moore RA; Mungall AJ; Walker B; Thomson T; Marra MA; Hirst M; Jones SJM
    J Endocrinol; 2017 Nov; 235(2):153-165. PubMed ID: 28808080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC-induced epigenetic activation of GATA4 in lung adenocarcinoma.
    Castro IC; Breiling A; Luetkenhaus K; Ceteci F; Hausmann S; Kress S; Lyko F; Rudel T; Rapp UR
    Mol Cancer Res; 2013 Feb; 11(2):161-72. PubMed ID: 23239811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone modifications for human epigenome analysis.
    Kimura H
    J Hum Genet; 2013 Jul; 58(7):439-45. PubMed ID: 23739122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic identification and annotation of human methylation marks based on bisulfite sequencing methylomes reveals distinct roles of cell type-specific hypomethylation in the regulation of cell identity genes.
    Liu H; Liu X; Zhang S; Lv J; Li S; Shang S; Jia S; Wei Y; Wang F; Su J; Wu Q; Zhang Y
    Nucleic Acids Res; 2016 Jan; 44(1):75-94. PubMed ID: 26635396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
    Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
    Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
    Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
    Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.
    Kaukonen D; Kaukonen R; Polit L; Hennessy BT; Lund R; Madden SF
    BMC Med Genomics; 2020 Jul; 13(1):92. PubMed ID: 32620123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.